The proper physiological activity of the endothelium—the single-cell layer lining blood vessels—including nitric oxide (NO) production for vasodilation, regulation of vascular permeability, antithrombotic activity, and anti-inflammatory signaling. Endothelial dysfunction is an early marker of cardiovascular disease and metabolic syndrome.
Healthy endothelium maintains vascular homeostasis through: (1) Nitric oxide production—endothelial nitric oxide synthase (eNOS) converts L-arginine to NO, causing smooth muscle relaxation and vasodilation, improving blood flow and reducing blood pressure, (2) Anti-inflammatory—prevents leukocyte adhesion (low VCAM-1, ICAM-1 expression), (3) Antithrombotic—produces prostacyclin (PGI2) preventing platelet aggregation, (4) Barrier integrity—tight junctions regulate permeability. Endothelial dysfunction occurs with: oxidative stress (reduces NO bioavailability as superoxide converts NO to peroxynitrite), chronic inflammation (TNF-α, IL-6 upregulate adhesion molecules), hyperglycemia (AGEs damage endothelium), dyslipidemia (oxidized LDL), smoking, sedentarism. Result is: reduced vasodilation (hypertension), increased permeability (edema), pro-inflammatory state (atherosclerosis), pro-thrombotic state.
Endothelial dysfunction is the earliest detectable stage of atherosclerosis and predictor of cardiovascular events. In cPNI, interventions targeting endothelial function are primary prevention: (1) Exercise—aerobic exercise increases eNOS expression and NO production, improves endothelial-dependent vasodilation, (2) Omega-3 fatty acids—reduce inflammation and oxidative stress, (3) Polyphenols—green tea, berries, cocoa improve NO bioavailability, (4) Sauna therapy—heat stress induces NO production and improves endothelial function, (5) Time-restricted eating—reduces postprandial oxidative stress, (6) Reduce inflammation—address AMPs driving chronic inflammation. Assessing endothelial function (flow-mediated dilation, pulse wave velocity) provides early cardiovascular risk stratification.
- Endothelium is single-cell layer lining all blood vessels
- Produces nitric oxide (NO) via eNOS for vasodilation
- Dysfunction is earliest stage of atherosclerosis
- Impaired by: oxidative stress, inflammation, hyperglycemia, dyslipidemia, smoking
- Exercise (especially aerobic) improves endothelial function via eNOS upregulation
- Sauna therapy enhances NO production and endothelial-dependent vasodilation
- Omega-3s and polyphenols support endothelial NO bioavailability
- Dysfunction manifests as: reduced vasodilation, increased permeability, inflammation, thrombosis
- Assessed via flow-mediated dilation, pulse wave velocity
- nitric oxide — endothelial function depends on NO production for vasodilation
- eNOS — endothelial nitric oxide synthase producing NO
- cardiovascular disease — endothelial dysfunction is earliest detectable stage
- atherosclerosis — initiated by endothelial dysfunction and inflammation
- physical exercise — aerobic exercise upregulates eNOS and improves endothelial function
- oxidative stress — reduces NO bioavailability, impairing endothelial function
- inflammation — chronic inflammation drives endothelial dysfunction
- omega-3 fatty acids — support endothelial function via anti-inflammatory effects
- sauna therapy — heat stress induces NO production and improves endothelial function
- polyphenols — improve NO bioavailability and endothelial function
- green tea — polyphenols support endothelial NO production
- hyperglycaemia — damages endothelium via AGE formation
- AGEs — advanced glycation end-products impair endothelial function
- TNF-α — inflammatory cytokine that upregulates endothelial adhesion molecules
- IL-6 — chronic elevation impairs endothelial function
- hypertension — results from endothelial dysfunction and reduced NO-mediated vasodilation
- time-restricted eating — reduces postprandial oxidative stress, protecting endothelium
- metabolic syndrome — strongly associated with endothelial dysfunction
- smoking — major driver of endothelial dysfunction via oxidative stress
- L-arginine — substrate for eNOS production of NO
- Module 2
- Module 5
- Module 8